These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12424510)

  • 1. Molecular links between obesity and cardiovascular disease.
    Sorisky A
    Am J Ther; 2002; 9(6):516-21. PubMed ID: 12424510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome and type 2 diabetes: role of the adipocyte.
    McPherson R; Jones PH
    Curr Opin Lipidol; 2003 Dec; 14(6):549-53. PubMed ID: 14624130
    [No Abstract]   [Full Text] [Related]  

  • 3. The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.
    Soltani Z; Washco V; Morse S; Reisin E
    Curr Hypertens Rep; 2015 Feb; 17(2):7. PubMed ID: 25620635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dysmetabolic syndrome: epidemiology and etiology.
    Sauerwein HP
    Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():1-13. PubMed ID: 16820727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular consequences of metabolic syndrome.
    Tune JD; Goodwill AG; Sassoon DJ; Mather KJ
    Transl Res; 2017 May; 183():57-70. PubMed ID: 28130064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin and cardiovascular disease: state of the art?
    Szmitko PE; Teoh H; Stewart DJ; Verma S
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1655-63. PubMed ID: 17142348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokines at the crossroad between obesity and cardiovascular disease.
    Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
    Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and the metabolic syndrome.
    Lann D; Gallagher E; Leroith D
    Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Syndrome in Polycystic Ovary Syndrome.
    Pasquali R
    Front Horm Res; 2018; 49():114-130. PubMed ID: 29894990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uric acid as a risk factor for cardiovascular diseases].
    Cibičková Ľ; Karásek D
    Vnitr Lek; 2016; 62(11):919-923. PubMed ID: 28128580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis.
    Makowski L; Hotamisligil GS
    Curr Opin Lipidol; 2005 Oct; 16(5):543-8. PubMed ID: 16148539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
    Pahwa R; Adams-Huet B; Jialal I
    J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of increased cardiovascular disease in obesity and metabolic syndrome.
    Vazzana N; Santilli F; Sestili S; Cuccurullo C; Davi G
    Curr Med Chem; 2011; 18(34):5267-80. PubMed ID: 22087824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The metabolic syndrome and inflammation: actual issues of pathogenesis].
    Sveklina TS; Talantseva MS; Barsukov AV
    Klin Lab Diagn; 2013 Mar; (3):7-10. PubMed ID: 23808015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome.
    Koren D; Taveras EM
    Metabolism; 2018 Jul; 84():67-75. PubMed ID: 29630921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
    Manco M
    J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for phytoinsulins as cardiovascular protector in metabolic syndrome.
    Ji L; Xing W; Dong L; Gao F
    Curr Pharm Des; 2013; 19(27):4848-58. PubMed ID: 23323618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension.
    Watson K
    Curr Cardiol Rep; 2006 Nov; 8(6):433-8. PubMed ID: 17059795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.